AGX-201

· AgoneX Biopharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AGX-201, covering 2022-07-20 to 2022-07-20. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous AGX-201 for Migraine Prophylaxis [Phase 2]

See pricing